Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Related Articles by Review for PubMed (Select 8713691)

1.

A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.

Webster J.

Drug Saf. 1996 Apr;14(4):228-38. Review. Erratum in: Drug Saf 1996 May;14(5):342.

PMID:
8713691
3.

Quinagolide--a valuable treatment option for hyperprolactinaemia.

Barlier A, Jaquet P.

Eur J Endocrinol. 2006 Feb;154(2):187-95. Review.

4.

Cabergoline: a new drug for the treatment of hyperprolactinaemia.

Ferrari C, Piscitelli G, Crosignani PG.

Hum Reprod. 1995 Jul;10(7):1647-52. Review.

PMID:
8582955
5.

Dopamine receptor agonists for treating prolactinomas.

Colao A, di Sarno A, Pivonello R, di Somma C, Lombardi G.

Expert Opin Investig Drugs. 2002 Jun;11(6):787-800. Review.

PMID:
12036422
6.

Diagnosis and drug therapy of prolactinoma.

Ciccarelli E, Camanni F.

Drugs. 1996 Jun;51(6):954-65. Review.

PMID:
8736617
7.

Current treatment issues in female hyperprolactinaemia.

Crosignani PG.

Eur J Obstet Gynecol Reprod Biol. 2006 Apr 1;125(2):152-64. Epub 2005 Nov 9. Review.

PMID:
16288952
8.

Hyperprolactinemia: pathophysiology and management.

Verhelst J, Abs R.

Treat Endocrinol. 2003;2(1):23-32. Review.

PMID:
15871552
9.

New drugs for hyperprolactinaemia.

[No authors listed]

Drug Ther Bull. 1995 Sep;33(9):65-7. Review.

PMID:
7588002
10.

Hyperprolactinemia: etiology, diagnosis, and management.

Mah PM, Webster J.

Semin Reprod Med. 2002 Nov;20(4):365-74. Review.

PMID:
12536359
11.

Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis.

dos Santos Nunes V, El Dib R, Boguszewski CL, Nogueira CR.

Pituitary. 2011 Sep;14(3):259-65. doi: 10.1007/s11102-010-0290-z. Review.

PMID:
21221817
12.

Hyperprolactinemia.

Biller BM.

Int J Fertil Womens Med. 1999 Mar-Apr;44(2):74-7. Review.

PMID:
10338264
13.

Clinical management of prolactinomas.

Webster J.

Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Oct;13(3):395-408. Review.

PMID:
10909431
14.

Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.

Colao A, Di Sarno A, Guerra E, De Leo M, Mentone A, Lombardi G.

Nat Clin Pract Endocrinol Metab. 2006 Apr;2(4):200-10. Review.

PMID:
16932285
15.
16.

Prolactin excess: treatment and toxicity.

Gillam MP, Fideleff H, Boquete HR, Molitch ME.

Pediatr Endocrinol Rev. 2004 Nov;2 Suppl 1:108-14. Review.

PMID:
16456489
17.

Prolactinoma in pregnancy.

Molitch ME.

Best Pract Res Clin Endocrinol Metab. 2011 Dec;25(6):885-96. doi: 10.1016/j.beem.2011.05.011. Review.

PMID:
22115164
18.

[Treatment of macroprolactinomas with quinagolide (Norprolac)].

Tabarin A, Catargi B.

Ann Endocrinol (Paris). 1997;58(2):87-94. Review. French.

PMID:
9239226
19.

A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.

Kvernmo T, Härtter S, Burger E.

Clin Ther. 2006 Aug;28(8):1065-78. Review.

PMID:
16982285
20.

[Prolactinoma and pregnancy].

Trifonov I.

Akush Ginekol (Sofiia). 2004;43 Suppl 2:16-22. Review. Bulgarian. No abstract available.

PMID:
15518268
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk